Cardiovascular Sciences, Inc.
CVSC
Other OTC0.00
USD
- -
- -
ISIN
US1416142065
Return %
Stock
S&P500
1Y
- -
26.84
3Y
- -
77.03
5Y
-99.67
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Larry Hooper
- Sector
- Consumer Cyclical
- Industry
- Personal Products & Services
- Address
- 3251 Progress Drive Heathrow United States of America
- IPO Date
- Oct 1, 2001
- Website
- cvsciences.org
- Similar Companies
- Business
- Cardiovascular Sciences, Inc. is a medical technology company specializing in the development and commercialization of products that address the treatment of cardiovascular diseases. The company's core offerings include proprietary anti-adhesion technology products designed to prevent post-surgical adhesions; its portfolio focuses on innovative solutions for cardiovascular and surgical applications. Cardiovascular Sciences operates primarily in the health care equipment sector with a focus on cardiovascular therapeutics and surgical intervention devices. The company serves healthcare providers and institutions across the United States and potentially in select international markets. Founded in 2001 and headquartered in Orlando, Florida, Cardiovascular Sciences has recently undertaken strategic initiatives to enhance its product offerings and expand operational capabilities. Its latest major changes include new product launches and possible strategic partnerships aimed at broadening its reach in cardiovascular treatment and innovative medical technology development. Cardiovascular Sciences, Inc. primarily develops and markets anti-adhesion technology products, which are used during and after surgical procedures to minimize tissue adhesion, a significant complication in cardiovascular surgeries. This positions the company within the medical device and healthcare equipment industry, targeting hospitals, surgical centers, and cardiovascular specialists. Recent company developments within the last 1-2 years highlight ongoing product innovation designed to improve surgical outcomes and reduce complications in cardiovascular and other surgeries. The company's headquarters and main operational base is located at 3251 Progress Drive, Orlando, Florida. Cardiovascular Sciences, Inc. is publicly traded under the ticker symbol CVSC on the OTC Markets. It continues to develop its market presence while investing in strategic advancements to solidify its role in cardiovascular medical technology. This description synthesizes available public and company data to present a comprehensive profile of Cardiovascular Sciences, Inc. focusing on core products, industry positioning, and recent strategic developments as pertains to cardiovascular medical solutions and surgical product innovation.